Expanding a short alcohol counseling program to help prevent HIV in Vietnam
Scaling up the brief alcohol intervention to prevent HIV infection in Vietnam: a cluster randomized, implementation trial
This project offers brief alcohol counseling at HIV clinics in Vietnam to help people with HIV drink less, stay on ART, and lower the chance of passing the virus to others.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11131216 on NIH RePORTER |
What this research studies
If I go to a participating HIV clinic in Vietnam, the clinic will either get extra support to deliver a short alcohol counseling program or that support plus an option for clinic staff to receive the counseling themselves as experiential learning. The extra support (facilitation) helps clinics overcome barriers like limited counselor skills, competing priorities, and resource gaps. Researchers will compare clinics to see how well the program reduces patients' drinking, improves ART adherence and viral suppression, and how easily the counseling can become routine care. The trial builds on earlier work in Vietnam showing the brief counseling reduced alcohol use and improved viral suppression.
Who could benefit from this research
Good fit: People living with HIV who use alcohol and receive care at participating antiretroviral treatment clinics in Vietnam are the ideal candidates.
Not a fit: People who do not drink alcohol, who are not cared for at participating clinics, or who need more intensive inpatient treatment for severe alcohol dependence may not benefit from this brief counseling approach.
Why it matters
Potential benefit: If successful, this could help people with HIV reduce drinking, improve ART adherence and viral suppression, and lower the risk of HIV transmission.
How similar studies have performed: Previous trials in Vietnam showed the brief alcohol intervention reduced alcohol use and increased viral suppression, and this trial tests ways to scale that success.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Go, Vivian F. — Univ of North Carolina Chapel Hill
- Study coordinator: Go, Vivian F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.